Andere talen Alkem Laboratories Limited Bombay S.E.

Aandelen

ALKEM

INE540L01014

Beurs gesloten - Bombay S.E. Andere beurzen 12:00:49 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4.871 ^INR	+3,39%		+2,90%	-6,19%

28/03	Alkem Laboratories richt dochteronderneming op voor activiteiten in medische hulpmiddelen	MT
28/03	Alkem Laboratories Limited kondigt de oprichting aan van dochteronderneming Alkem Medtech Private Limited	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak	16/04
Alkem Laboratories Forms Subsidiary for Medical Devices Business	28/03
Alkem Laboratories Limited Announces Incorporation of Subsidiary Alkem Medtech Private Limited	28/03
Alkem Laboratories Gets 10 Observations from US FDA After Baddi, India Unit Inspection	28/03
Norway's Biosergen Secures Indian Regulatory Approval for Clinical Trial of Fungal Infections Therapy	12/02
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.	12/02
Alkem Laboratories Limited Approves Interim Dividend for Financial Year 2023-24 , Payable on 1 March, 2024	09/02
Alkem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Research Update Biosergen: Licensing deal with Alkem and CTA submission	16/01
Indian Equities Close Higher on Friday, Lifted by IT Stocks	12/01
Alkem Laboratories Names Successor to Outgoing CFO	12/01
Alkem Laboratories Limited Announces CFO Changes	12/01
Heritage Global, Investors Acquire Pharmaceutical Plant from Alkem Laboratories	11/01
Federal Machinery & Equipment Co., Heritage Global Partners, Inc., New Mill Capital LLC, Keith Machinery Corp acquired Pharmaceutical Site in Fenton Missouri from Alkem Laboratories Limited.	11/01
Alkem Laboratories Limited Appoints Ashish Sehgal to Hold Senior Management Position in the Company Effective 15 December 2023	15/12
Biosergen's Partner Alkem Laboratories Submits Clinical Trial Application for First Patient Study with BSG005 in Invasive Fungal Infections in India as a Rescue Therapy	12/12
Alkem Laboratories Limited Submits Clinical Trial Application to Central Drugs Standard Control Organization in India	12/12
Alkem Laboratories Limited Submits Clinical Trial Application for First Patient Study with Bsg005 in Invasive Fungal Infections in India as A Rescue Therapy	12/12
Biosergen's Indian Partner Seeks Approval for Clinical Trial of Antifungal Drug Candidate	12/12
Alkem Laboratories Limited Appoints Kaustav Banerjee to Hold Senior Management Position	05/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Alkem Laboratories Limited Bombay S.E.

Aandelen

ALKEM

INE540L01014

Andere talen

Filters